当前位置: X-MOL 学术Biomed. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
1O, 20O-diacetyl kamebakaurin protects against acetaminophen-induced hepatotoxicity in mice.
Biomedical Research ( IF 1.2 ) Pub Date : 2018-10-20 , DOI: 10.2220/biomedres.39.251
Hiroki Yoshioka 1 , Tsunemasa Nonogaki 1 , Hiroyuki Ohnishi 2 , Nobuyuki Fukuishi 1 , Masae Yoshikawa 1 , Ming-Yu Gui 3 , Yong-Ri Jin 3 , Xu-Wen Li 3 , Yoshiyuki Adachi 4 , Naohito Ohno 4 , Koichi Takeya 4 , Yukio Hitotsuyanagi 4 , Nobuhiko Miura 5 , Yutaka Aoyagi 1
Affiliation  

The present study aimed to investigate the protective effects of kamebakaurin (KA) and 1O, 20O-diacetyl kamebakaurin (Ac2KA) on acetaminophen (APAP)-induced hepatotoxicity and compare the hepatoprotective mechanisms of the two chemicals. Seven-week-old male C57BL/6J mice were orally administered KA, Ac2KA, or an ethanol/olive oil emulsion once per day for 7-days. Twenty-four hours after the final administration, the mice were fasted and then intraperitoneally injected with 450 mg/kg APAP or saline. At 16 h after injection, the mice were euthanized and blood samples were collected for plasma analysis. Pretreatment with KA and Ac2KA significantly attenuated APAP-induced hepatic injury. The protective effect of Ac2KA was stronger than that of KA. These two chemicals attenuated oxidative stress, inflammatory cytokine production, c-jun N-terminal kinase activation, and receptor-interacting protein (RIP)-3 activation. Ac2KA also decreased APAP-induced RIP-1 activation and nuclear factor kappa B (NF-κB) p65 translocation. Moreover, Ac2KA repressed mRNA expression of Cyp1a2/2e1 in the liver. Our results showed that KA and Ac2KA exerted protective effects against APAP-induced hepatotoxicity. The responsible mechanisms may be related to the chemicals' antioxidant activity and the inhibition of c-jun N-terminal kinase activation and RIP-3 activation. The effects of Ac2KA included those of KA, as well as RIP-1 inactivation, NF-κB inhibition, and Cyp inhibition.

中文翻译:

1O,20O-二乙酰基kamebakaurin可防止对乙酰氨基酚引起的小鼠肝毒性。

本研究旨在调查kamebakaurin(KA)和1O,20O-二乙酰基kamebakaurin(Ac2KA)对对乙酰氨基酚(APAP)诱导的肝毒性的保护作用,并比较两种化学药品的保肝作用。每天一次给7周大的雄性C57BL / 6J小鼠口服KA,Ac2KA或乙醇/橄榄油乳液,持续7天。最后一次给药后24小时,将小鼠禁食,然后腹膜内注射450mg / kg APAP或盐水。注射后16小时,对小鼠实施安乐死并收集血样用于血浆分析。KA和Ac2KA预处理可显着减轻APAP诱导的肝损伤。Ac2KA的保护作用强于KA。这两种化学物质减弱了氧化应激,炎性细胞因子的产生,c-jun N末端激酶激活和受体相互作用蛋白(RIP)-3激活。Ac2KA还降低了APAP诱导的RIP-1激活和核因子κB(NF-κB)p65易位。此外,Ac2KA抑制肝脏中Cyp1a2 / 2e1的mRNA表达。我们的结果表明,KA和Ac2KA对APAP诱导的肝毒性具有保护作用。可能的机制可能与化学品的抗氧化活性以及c-jun N末端激酶激活和RIP-3激活的抑制有关。Ac2KA的作用包括KA的作用,以及RIP-1失活,NF-κB抑制和Cyp抑制。Ac2KA抑制肝脏中Cyp1a2 / 2e1的mRNA表达。我们的结果表明,KA和Ac2KA对APAP诱导的肝毒性具有保护作用。可能的机制可能与化学品的抗氧化活性以及c-jun N末端激酶激活和RIP-3激活的抑制有关。Ac2KA的作用包括KA的作用,以及RIP-1失活,NF-κB抑制和Cyp抑制。Ac2KA抑制肝脏中Cyp1a2 / 2e1的mRNA表达。我们的结果表明,KA和Ac2KA对APAP诱导的肝毒性具有保护作用。可能的机制可能与化学品的抗氧化活性以及c-jun N末端激酶激活和RIP-3激活的抑制有关。Ac2KA的作用包括KA的作用,以及RIP-1失活,NF-κB抑制和Cyp抑制。
更新日期:2019-11-01
down
wechat
bug